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a b s t r a c t
Background: AFRIMS longitudinal dengue surveillance in Thailand depends on the nested RT-PCR and the
dengue IgM/IgG ELISA.
Objective: To examine and improve the sensitivity of the nested RT-PCR using a panel of archived samples
collected during dengue surveillance.
Study design: A retrospective analysis of 16,454 dengue IgM/IgG ELISA positive cases collected between
2000 and 2013 was done to investigate the sensitivity of the nested RT-PCR. From these cases, 318 acute
serum specimens or extracted RNA, previously found to be negative by the nested RT-PCR, were tested
using TaqMan real-time RT-PCR (TaqMan rRT-PCR). To improve the sensitivity of nested RT-PCR, we
designed a new primer based on nucleotide sequences from contemporary strains found to be positive
by the TaqMan rRT-PCR. Sensitivity of the new nested PCR was calculated using a panel of 87 samples
collected during 2011–2013.
Results and conclusion: The percentage of dengue IgM/IgG ELISA positive cases that were negative by the
nested RT-PCR varied from 17% to 42% for all serotypes depending on the year. Using TaqMan rRT-PCR,
dengue RNA was detected in 194 (61%) of the 318 acute sera or extracted RNA previously found to be
negative by the nested RT-PCR. The newly designed DENV-1 specific primer increased the sensitivity of
DENV-1 detection by the nested RT-PCR from 48% to 88%, and of all 4 serotypes from 73% to 87%. These
findings demonstrate the impact of genetic diversity and signal erosion on the sensitivity of PCR-based
methods.
Published by Elsevier B.V.
1. Background
Dengue virus (DENV), a mosquito-borne flavivirus, is transmit-
ted to humans primarily by Aedes aegypti and Aedes albopictus.
DENV infection is estimated to occur in 390 million people per
year worldwide [1]. This is likely to increase due to the expand-
ing geographic distribution of both viruses and vectors. There are
∗ Corresponding author at: Armed Forces Research Institute of Medical Sciences,
US Army Medical Component, 315/6 Rajvithi Road, Bangkok 10400, Thailand.
Tel.: +66 2 696 2700; fax: +66 2 644 4760.
E-mail address: Chontichak@afrims.org (C. Klungthong).
four antigenically distinct serotypes (DENV-1–DENV-4) that can
cause infections in humans with clinical manifestations ranging
fromasymptomatic infection to undifferentiated fever, self-limited
dengue fever (DF), dengue hemorrhagic fever (DHF) and dengue
shock syndrome (DSS) [2–4]. The 11kb single-stranded positive-
sense viral RNA genome contains a single open reading frame (ORF)
encoding the structural capsid (C), pre-membrane/membrane
(prM/M) and envelope (E) proteins, and the nonstructural (NS)
proteins; NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5 [5].
DENV surveillance provides important information used for
forecasting, outbreak control, and epidemiological studies [6–8].
Routine DENV laboratory testing at the Department of Virology,
Armed Forces Research Institute of Medical Sciences (AFRIMS)
http://dx.doi.org/10.1016/j.jcv.2014.12.009
1386-6532/Published by Elsevier B.V.
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supports DENV longitudinal surveillance. Laboratory detection
relies primarily on the dengue nested RT-PCR (nested RT-PCR),
dengue IgM/IgG enzyme-linked immunosorbent assay (IgM/IgG
ELISA), and DENV isolation using C6/36 culture or intrathoracic
inoculation of Toxorhynchites splendens mosquitoes [6–8]. Acute
serum specimens from patients with suspected DENV infection
are tested by nested RT-PCR, while paired acute and convalescent
specimens are tested by IgM/IgG ELISA.
Nested RT-PCR method is widely used throughout the world
and has been used in our dengue surveillance program since 1994
[6–9]. The results have provided important epidemiological infor-
mation concerning cyclic serotype predominance and fluctuations
in DF/DHF [6–8]. In addition, positive nested RT-PCR samples
have been used for molecular epidemiology and evolution stud-
ies based on E gene and/or complete genome sequences. These
studies have provided details of the genotypes or clades circulating
in Thailand [10–12]. Although the nested RT-PCR method is more
time-consuming and has a higher risk of contamination than real-
time RT-PCR (rRT-PCR) [13–20], the cost of the assay is significantly
lower making it the preferred method for DENV detection in many
laboratories.
2. Objectives
To examine the percentage of false negative nested RT-PCR
results found in routine dengue surveillance conducted in Thailand




We retrospectively analyzed dengue IgM/IgG ELISA and nested
RT-PCR data from previous tests performed on serum specimens
collected from patients admitted to Queen Sirikit National Insti-
tute of Child Health (QSNICH) in Bangkok and Kamphaeng Phet
Provincial Hospital (KPPH) in Kamphaeng Phet province (north-
ern Thailand) from 2000 to 2013. We examined the results from
16,454 acute dengue cases confirmed by IgM/IgG ELISA for which
the number of days of illness (DOI) at the time of specimen col-
lection was known. The sensitivity, specificity, positive predictive
value (PPV), negative predictive value (NPV) and 95% confidence
interval (CI) of all RT-PCR methods were calculated using MedCalc
software [21]. For comparisonsbetweensensitivities obtained from
different RT-PCR methods, we used McNemar exact test [22].
3.2. Human sera, extracted RNA and DENV isolates
Acutehuman serumspecimens (n=300) or RNAextracts (n=18)
from 318 dengue cases that were previously determined to be pos-
itive by IgM/IgG ELISA, but negative by nested RT-PCR were tested
by an in-house TaqMan rRT-PCR assay (Table 1). These samples
were selected from the available samples collected from 2005 to
2013. The sensitivity and specificity of the nested RT-PCR using the
DENV-1 specific primer (TS1) or the newly designed DENV-1 spe-
cific primer (TS1.2013TH) were tested using a panel of 87 samples
(Table 1) composed of 72 RNA samples extracted from acute serum
specimens collected from 2012 to 2013 and 15 DENV isolates (all
serotypes at 104 pfu/ml or higher) isolated from acute serum spec-
imens collected in 2011 (these specimens were not available). This
panel was tested in parallel by the nested RT-PCR using TS1 primer,
the nested RT-PCR using TS1.2013TH primer, the TaqMan rRT-PCR
and theDENV-1-4 rRT-PCRdeveloped by theU.S. Center forDisease
Control andPrevention (CDC) and recently licensedby theU.S. Food
Fig. 1. Flowchart of the study design.
and Drug Administration (FDA) for diagnostic use. All these assays
are serotyping assays. A flowchart for this study is shown in Fig. 1.
3.3. RNA extraction
Viral RNA was extracted from acute serum specimens using
QIAamp Viral RNA Mini Kit (QIAGEN, Germany) according to the
manufacturer’s instructions. The extracted RNA was preserved in
the elution buffer at −70 ◦C until use in RT-PCR assays.
3.4. TaqMan rRT-PCR and Nested RT-PCR
TaqMan rRT-PCR was modified from Sadon et al. [13]
by using the new DENV-1 primers and probe (TMF 5′-
gcattyctaagatttctagccatacc-3′, TMR 5′-tcgctccattcttcttgaatgag-3′,
and TMP 5′-aacagcaggaatttt-3′). One-Step RT-PCR kit (Ambion,
USA) was used in this assay. Accumulation of PCR products was
detected by monitoring the fluorescence emitted by probe hydrol-
ysis using SDS software. The amplification cycle (Ct value) at which
fluorescence was detected above the threshold was determined.
A sample was defined as positive if the Ct value was <40 based
on background cross-reactivity of the primers and probes in non-
template control reactions. The nested RT-PCR was performed
according to the protocol of Lanciotti et al. with modifications as
describedbyKlungthonget al. [9,23]. A specimencontainingDENV-
1, 2, 3 or 4 was identified by the detection of a DNA band of 482,
119, 290, or 392 base pairs (bp), respectively, on the gel loaded
with nested PCR product corresponding to DNA amplified from the
DENV genome in positive controls. The sequences of all primers
used in nested RT-PCR are described in Table 2.
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Table 1
Number and types of samples tested in this study.
Test Year of collection Number of samples Sample types
TaqMan rRT-PCR 2005 45 Human sera from IgM/IgG ELISA positive and nested RT-PCR negative cases
2006 44 Human sera from IgM/IgG ELISA positive and nested RT-PCR negative cases
2007 36 Human sera from IgM/IgG ELISA positive and nested RT-PCR negative cases
2008 88 Human sera from IgM/IgG ELISA positive and nested RT-PCR negative cases
2009 43 Human sera from IgM/IgG ELISA positive and nested RT-PCR negative cases
2010 44 Human sera from IgM/IgG ELISA positive and nested RT-PCR negative cases
2012 15 RNA from IgM/IgG ELISA positive and nested RT-PCR negative cases




2011 15 DENV isolates
2012 12 RNA from IgM/IgG ELISA and nested RT-PCR positive cases
2012 15 RNA from IgM/IgG ELISA positive and nested RT-PCR negative cases
2012 13 RNA from IgM/IgG ELISA and nested RT-PCR negative cases
2013 22 RNA from IgM/IgG ELISA and nested RT-PCR positive cases
2013 3 RNA from IgM/IgG ELISA positive and nested RT-PCR negative cases
2013 7 RNA from IgM/IgG ELISA and nested RT-PCR negative cases
Total 87
Table 2
List of primers used in nested RT-PCR.
Primer Namea Sequence (5′-3′)b Serotype specificity Genome positionc Size (bp) of amplified DNA product (primers)d
D1 tcaatatgctgaaacgcgcgagaaaccg DENV-1–4 134–161 NA
D2 ttgcaccaacagtcaatgtcttcaggttc DENV-1–4 616–644 511 (D1 and D2)
TS1 cgtctcagtgatccggggg DENV-1 581–599 482 (D1 and TS1)
TS2 cgccacaagggccatgaacag DENV-2 232–252 119 (D1 and TS2)
TS3 taacatcatcatgagacagagc DENV-3 400–421 290 (D1 and TS3)
TS4 ctctgttgtcttaaacaagaga DENV-4 506–527 392 (D1 and TS4)
TS1.2013TH mgcytcagtgattckagg DENV-1 582–599 482 (D1 and TS1.2013TH)
a D1 is a forward primer and the others are reverse primers. D1 and D2 are used for RT-PCR. D1, TS1, TS2, TS3, TS4 and TS1.2013TH are used for nested PCR.
b Sequences of D1, D2, TS1–4 primers are obtained from Lanciotti et al. [9]. Sequence of TS1.2013TH primer is obtained from this study.
c The genome positions of D1 and D2 are given according to DENV-2 strain ThNH81/93 (GenBank Accession No. AF169688) and those of TS1.2013TH, TS2, TS3, and TS4 are
based on the numbering of DENV-1Cambodia strain (GenBank Accession No.AF309641), DENV-2 ThNH81/93 strain (GenBank Accession No. AF169688), DENV-3 80–2 strain
(GenBank Accession No. AF317645), and DENV-4 814669 strain (GenBank Accession No. AF326573), respectively.
d The size of the amplified product obtained from each of the type-specific primers (TS1–TS4) is determined from the priming position of primer D1 within each respective
genome. The priming position for D1 in each DENV genome is as follows: type 1: 118–145; type 2: 134–161; type 3: 132–159; and type 4: 136–163.
3.5. TS1.2013TH primer design
The C/prM gene sequences were obtained from 10 contempo-
rary DENV-1 strains tested by IgM/IgG ELISA, nested RT-PCR and
TaqMan rRT-PCR, and from16other sequences retrieved fromGen-
Bank. All sequences were analyzed and compared to the sequence
of the nested RT-PCR primers (Fig. 2). The primer TS1.2013TH was
designed based on the TS1 primer binding site sequences and was
used to replace the TS1 primer (Table 2).
3.6. CDC DENV-1-4 rRT-PCR
The CDC DENV 1-4 rRT-PCR was used for comparison of the
sensitivity of DENV detection against the other three methods
including thenestedRT-PCRusing theDENV-1 specific TS1primers,
nested RT-PCR using the DENV-1 specific TS1.2013TH primer, and
TaqMan rRT-PCR. The assay was performed using a kit provided by
the CDC and following their previously described protocol [15,16].
4. Results
4.1. Analysis of nested RT-PCR results obtained from dengue
IgM/IgG ELISA positive cases
We evaluated 16,454 acute serum specimens collected during
2000–2013 andwhichwere positive for DENV by IgM/IgG ELISA. Of
these cases, 69% (11,311/16,454) were nested RT-PCR positive and
31% (5143/16,454) were nested RT-PCR negative, suggesting that
the nested RT-PCR may have had suboptimal sensitivity. The rate
ofnegativenestedRT-PCR results ranged from17 to42%, depending
on the year (Fig. 3). When we stratified the results into 0–5 and >5
DOI groups (Table 3), the rate of negative nested RT-PCR among
specimens collected after 5 DOI was 53% (1823/3,418) compared
to 25% (3320/13,036) among specimens collected at 0–5 DOI.
4.2. Detection and serotyping of DENV by TaqMan rRT-PCR
We selected 318 samples that were IgM/IgG ELISA positive
(Table 1) but nested RT-PCR negative, and tested them by Taq-
Man rRT-PCR. These samples included 181 (57%) samples collected
within 0–5 DOI and 137 (43%) samples collected >5 DOI. Of these,
194 (61%) were positive for DENV by TaqMan rRT-PCR (Table 4),
including 142 DENV-1 (45%), 40 DENV-2 (13%), 4 DENV-3 (1%), 0
DENV-4 (0%) and 8 with both DENV-1 and DENV-2 (2%). Among
the positive results, 65% (118/181) and 55% (76/137) were from
samples collected within 0–5 and >5 DOI, respectively.
Table 3
Number and percentages of nested RT-PCR positive and negative results of dengue
IgM/IgG ELISA positive cases with known days of illness.
Nested RT-PCR results Number of samples with
different days of illnessa (%)
Total (%)
0–5 DOI >5DOI
Positive 9716 (75) 1595 (47) 11311 (69)
Negative 3320 (25) 1823 (53) 5143 (31)
Total 13036 3418 16454
a DOI: days of illness.
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Fig. 2. Nucleotide alignment of TS1 primer binding regions from 26 DENV-1 strains including 10 Thai strains used in this study and 16 other strains from GenBank (GenBank
Accession No. AB189121, AF309641, AY858983, FJ687428, JF459993, JN697058, JN819423, KF955444, KC172832, JQ045668, GQ868602, GQ398255, EU081262, DQ672557,
DQ672564, and EU482591). TS1 and TS1.2013TH sequences shown in this figure are reverse complement sequences of TS1 and TS1.2013TH primers, respectively. Genome
positions are given according to DENV-1 Singapore strain GenBank accession number GQ398255. The dots represent the bases common to most strains.
Fig. 3. Percentages of nested RT-PCR positive and negative results from dengue
IgM/IgG ELISA positive cases in each year.
4.3. DENV-1 primer binding sites analysis
Given the high percentage (45%) of misdetection by the nested
RT-PCR among DENV-1, we analyzed the sequences of the primer
binding sites within the C/prM gene regions obtained from 10
DENV-1 collected during 2005, 2009–10, and 2012–13 that were
positive by IgM/IgG ELISA and TaqMan rRT-PCR, but negative
by nested RT-PCR. Table 5 shows the number of mismatched
nucleotides of the templates against the sequences of the nested
RT-PCR primers. There were no mismatches in the forward primer
(D1) binding site in any of the 10 samples. However, the sequences
of all 10 samples displayed 4–6 mismatches in the first round
reverse primer (D2) binding site and 2–4 mismatches in the sec-
ond round primer binding site (TS1). Based on these sequences, we
designed a new DENV-1 specific primer, TS1.2013TH, to replace
TS1. TS1.2013TH is one base shorter than TS1 and is different by 6
bases (Table 2).
4.4. Sensitivity and specificity of DENV detection by nested
RT-PCR using the TS1.2013TH primer.
Using the TS1.2013TH primer, we tested the sensitivity and
specificity of the nested RT-PCR using a panel of 87 samples col-
lected during 2011–2013 (Table 1). The same samples were tested
in parallel with the nested RT-PCR using the TS-1 primer, the Taq-
Man rRT-PCR and the CDC rRT-PCR. The sensitivity, specificity,
PPV, and NPV of DENV detection of all 4 DENV serotypes are
summarized in Table 6. The nested RT-PCR using TS-1 primer
showed the lowest overall sensitivity (73%) and the lowest NPV
Table 4
TaqMan rRT-PCR results of 318 samples from dengue IgM/IgG ELISA positive cases
with nested RT-PCR negative result.
TaqMan rRT-PCR results Number of samples by
DOIa (%)
Total (%)
0–5 DOI >5 DOI
Positive 118 (65) 76 (55) 194 (61)
DENV-1 77 (43) 65 (47) 142 (45)
DENV-2 31 (17) 9 (7) 40 (13)
DENV-3 4 (2) 0 (0) 4 (1)
DENV-1 and DENV-2 6 (3) 2 (1) 8 (2)
Negative 63 (35) 61 (45) 124 (39)
Total 181 137 318
a DOI: days of illness.
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Table 5
Sequences of primer-binding sites of 10 DENV-1.
Primer region on DENV-1 template Sequences of primer attached
regions of 10 samplesa
No. of mismatched
nucleotides
No. of viruses containing the examined
sequence/total tested No.
Forward primer D1 region (5′-3′) tcaatatgctgaaacgcgcgagaaaccg 0 10/10
Reverse primer D2 region (5′-3′) ttgcaccaacaAtcaaCgtcAtcTggttc 4 6/10
ttAcaccaacaAtcaaCgtcAtcTggttc 5 3/10
ttAcaccaGcaAtcaaCgtcAtcTggttc 6 1/10




a The mismatched nucleotides against the sequences of primers are shown with bold capital letter.
Table 6
Sensitivity and specificity of DENV detection using the four methods.










PPV (95% CI) NPV (95% CI)
Nested RT-PCR, TS1primer, positive 49 0 49 73 (61–83) 100 (76–100) 100 (89–100) 53 (36–69)
Nested RT-PCR, TS1 primer, negative 18 20 38
Total 67 20 87
Nested RT-PCR,TS1.2013TH, positive 58 0 58 87 (76–94) 100 (76–100) 100 (91–100) 69 (49–85)
Nested RT-PCR,TS1.2013TH, negative 9 20 29
Total 67 20 87
TaqMan rRT-PCR, positive 58 0 58 87 (76–94) 100 (76–100) 100 (91–100) 69 (49–85)
TaqMan rRT-PCR, negative 9 20 29
Total 67 20 87
CDC rRT-PCR, positive 57 0 57 85 (74–93) 100 (76–100) 100 (91–100) 67 (47–83)
CDC rRT-PCR, negative 10 20 30
Total 67 20 87
(53%). The sensitivity improved to 87% when using the TS1.2013TH
primer (P=0.022), while the NPV increased to 69%. The sensi-
tivity of the nested RT-PCR using the TS1.2013TH primer was
comparable to that of the TaqMan and the CDC rRT-PCR (87%
and 85%;respectively, P=1.000). The sensitivity varied for each
serotype and is summarized in Table 7. The sensitivity of the
nested RT-PCR using the TS-1 primer was only 48% for DENV-1,
while that for the other 3 serotypes were 92% or better. Using
the TS1.2013TH primer significantly increased the sensitivity for
DENV-1 to 88% (P=0.006), comparable to that of the TaqMan
(100%) and the CDC rRT-PCR (88%) (P=0.250 and 1.000, respec-
tively). There were no significant differences in the sensitivity of
detection for the other serotypes by the nested RT-PCR using the
TS1.2013TH primer when compared with the other three meth-
ods (P>0.05). We also attempted modifications to the first round
reverse primer, D2 primer, but the results showed lower sensi-
tivity and specificity (data not shown). All four methods showed
100% specificity. The nested RT-PCR using the TS1.2013TH primer
was also tested using purified RNA obtained from chikungunya,
Japanese encephalitis, West Nile, and Zika viruses. There was no
PCRproductwithdengue-specific size detected from these samples
(data not shown).
4.5. DENV detection sensitivity by multiple RT-PCR methods and
stratified by DOI.
Among the 87 samples tested by all four RT-PCR methods, 72
were RNA samples previously extracted from acute serum. These
samples had a recorded DOI. The sensitivities of the four methods
tested with these 72 samples were analyzed based on DOI and are
shown in Table 8. The nested RT-PCR using TS1 primer showed the
lowest DENV detection sensitivity in samples collected at 0–5 and
>5 DOI (89% and 38%, respectively). However, replacement of the
DENV-1 specific primer with the TS1.2013TH primer significantly
improved the sensitivity (96%) of the nested RT-PCR and made it
comparable to the sensitivities of all the methods (P>0.05) among
samples collected at 0–5 DOI. For samples collected at >5 DOI, the
sensitivity of the nested RT-PCR increased to 67% when using the
TS1.2013TH primer (P=0.07). This sensitivity was comparable to
the TaqMan (71%) and the CDC rRT-PCR (67%) (P=1).
5. Discussion
Nested RT-PCR is a cost-effective, rapid and sensitive diagnostic
and surveillance tool used for the detection and identification of
Table 7
DENV serotype detection sensitivity by all RT-PCR methods.
Methods Sensitivity of DENV detection (95% CI)
All serotypes DENV-1a(n=25) DENV-2a(n=12) DENV-3a(n=13) DENV-4a(n=13)
Nested RT-PCR, TS-1 primer 73 (61–83) 48 (28–69) 92 (61–99) 100 (75–100) 100 (75–100)
Nested RT-PCR, TS1.2013TH primer 87 (76–94) 88 (69–97) 92 (61–99) 92 (64–99) 100 (75–100)
TaqMan rRT-PCR 87 (76–94) 100 (80–100) 100 (73–100) 69 (39–91) 92 (64–99)
CDC rRT-PCR 85 (74–93) 88 (69–97) 92 (61–99) 100 (75–100) 85 (55–98)
a The DENV serotypes among the ELISA positive samples (n=48) and virus isolates (n=15) were determined by one or more RT-PCR methods tested in this study.
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Table 8
Sensitivity of DENV detection of 72 samples based on days of illness.













Nested RT-PCR, TS-1 primer
Positive 25 0 25 89 (72–98) 9 0 9 38 (19–59)
Negative 3 10 13 15 10 25
Total 28 10 38 24 10 34
Nested RT-PCR, TS1.2013TH
Positive 27 0 27 96 (82–100) 16 0 16 67 (45–84)
Negative 1 10 11 8 10 18
Total 28 10 38 24 10 34
TaqMan rRT-PCR
Positive 26 0 26 93 (76–99) 17 0 17 71 (49–87)
Negative 2 10 12 7 10 17
Total 28 10 38 24 10 34
CDC rRT-PCR
Positive 26 0 26 93 (76–99) 16 0 16 67 (45–84)
Negative 2 10 12 8 10 18
Total 28 10 38 24 10 34
a DOI: days of illness.
DENV in acute specimens. It continues to be widely used in clinical,
epidemiological and entomological studies [6–8,24–29]. Nonethe-
less, due to the accumulated spatiotemporally-dependent changes
in the virus genome, continuous monitoring of assay sensitivity is
required to ensure the validity and accuracy of the assay.
A modified Lanciotti nested RT-PCR method has been used to
support surveillance and epidemiological studies [6–8,10–12]. This
method was deemed optimal for DENV diagnosis and surveillance
by an international external quality control assessment (EQA) [30].
However, this evaluation was based on blind panels of diluted
DENV control strains that no longer represent currently circulating,
DENV strains: DENV-1VR344 (Thailand 1958), DENV-2VR345 (TH-
36 strain, Thailand 1958), DENV-3 VR216 (H87 strain, Philippines
1956) and DENV-4 VR217 (H241 strain, Philippine 1956). Routine
monitoring of the assay using circulating strains may be a more
suitable method for quality control and assay validation. Our anal-
ysis of nested RT-PCR results of samples containing DENV collected
during the past 14 years (2000–2013) showed a 31% false negative
rate, ofwhich25%were samples collectedwhenviremia is common
(5 days or less after the onset of symptoms) [31]. Genetic variations
at the sites of primer binding are likely to have contributed to this
high rate of false negatives.
DENV has no proof-reading activity during replication and has
almost 8%nucleotide sequencediversity amongDENVswithin each
serotype [32]. Nucleotide changesmay limit the sensitivity ofDENV
detection by genomic amplification methods like RT-PCR. The Taq-
Man rRT-PCR used in this study could detect up to 61% of DENV
from samples that could not be detected previously by the nested
RT-PCR using the TS1 primer. Among the TaqMan rRT-PCR positive
samples, 45% were DENV-1. This was consistent with a previous
report that TaqMan rRT-PCR sensitivity forDENV-1washigher than
nested RT-PCR [13]. This was also consistent with our surveillance
data showing that DENV-1 circulated at the highest frequency dur-
ing 2005–2013 (data not published). Using TaqMan rRT-PCR, we
detected DENV in acute serum specimens collected at 0–5 and >5
DOI (65% and 55%, respectively), indicating that despite the pres-
ence of DENV genomic RNA in samples collected early and late
during illness, we could not detect it by nested RT-PCR. This sug-
gested that the TS-1 primer designed based on DENV sequences
circulating during 1986–1990 had lower sensitivity for contempo-
rary viruses.
Since DENV-1 detection showed the lowest sensitivity and
a high number of mismatches at the TS-1 primer binding site,
we designed the DENV-1 specific TS1.2013TH primer based on
sequences obtained from contemporary DENV-1 strains. Using
TS1.2013TH, the sensitivity of DENV detection improved from 73%
to87% for allDENVserotypes, and forDENV-1detection from48% to
88%. In addition, the sensitivity ofDENVdetectionbynestedRT-PCR
increased when using the new primer not only in samples col-
lected 0–5 days after illness onset but also in samples collected >5
days after illness onset. The sensitivity and specificity for the other
serotypes were not affected when using the TS1.2013TH primer.
The improved sensitivity obtained by using the new primer was
comparable to that of the TaqMan and the CDC rRT-PCR.
In conclusion, the sensitivity of the nested RT-PCR was substan-
tially improvedby thedevelopment of a newprimer. Thesefindings
highlight the impactof geneticdiversityon the sensitivityofRT-PCR
methods, a critical concern for assay development, quality control,
and surveillance.
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